Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTRK3 | Q16288 | 1/20 | 0.43 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.43 |
| ▸ | MAPT | P10636 | 7/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.43 |
| ▸ | MEN1 | O00255 | 5/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13640138 | 0.85 | KMT2A (0.49) | ALDH1A1MAPTKMT2AMEN1KDM4E | |
| SCHEMBL12830161 | 0.85 | ALDH1A1 (0.43) | ALDH1A1MAPTKMT2AMEN1KDM4E | |
| SCHEMBL13640141 | 0.84 | ALDH1A1 (0.60) | ALDH1A1MAPTKMT2AMEN1KDM4E | |
| SCHEMBL22057718 | 0.84 | MAOA (0.45) | ALDH1A1MAPTKMT2AMEN1KDM4E | |
| SCHEMBL8428005 | 0.84 | MAPT (0.51) | ALDH1A1MAPTKMT2AMEN1KDM4E | |
| SCHEMBL13640144 | 0.84 | ALDH1A1 (0.42) | ALDH1A1MAPTKMT2AMEN1KDM4E | |
| SCHEMBL11109819 | 0.83 | ALDH1A1 (0.60) | ALDH1A1MAPTKMT2AGAATSHR | |
| SCHEMBL12316747 | 0.81 | ALDH1A1 (0.40) | ALDH1A1MAPTKMT2AMEN1KDM4E | |
| SCHEMBL13640474 | 0.81 | TSHR (0.43) | ALDH1A1MAPTKDM4EGAATSHR | |
| SCHEMBL22056817 | 0.80 | L3MBTL1 (0.51) | ALDH1A1MAPTKMT2AMEN1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2477491-B1 | PLANT ADDITIVES AND USES THEREOF TO MODULATE THE SYNTHESIS OF MEMBRANE GLYCEROLIPIDS IN PLANTS | COMMISSARIAT L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2017-05-17 | — | — | EP | disclosed |
| US-9028855-B2 | Plant additives and uses thereof to modulate the synthesis of membrane glycerolipids in planta | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2015-05-12 | — | — | US | disclosed |
| US-9028855-B2 | Plant additives and uses thereof to modulate the synthesis of membrane glycerolipids in planta | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2015-05-12 | — | — | US | disclosed |
| US-20120283101-A1 | Plant Additives and Uses Thereof to Modulate the Synthesis of Membrane Glycerolipids in Planta | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2012-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120283101-A1 | Plant Additives and Uses Thereof to Modulate the Synthesis of Membrane Glycerolipids in Planta | PGM2, SGMS2, PHOSPHO1 | NTRK3 4529/4885NTRK2 4302/4885ALDH1A1 3248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.